Hepatitis B virus mutations associated with antiviral therapy

Journal of Medical Virology
Angeline Bartholomeusz, Stephen Locarnini

Abstract

The hepatitis B virus (HBV) replicates via an error prone viral reverse transcriptase resulting in a large pool of quasispecies with mutations spread throughout the genome. During antiviral drug selection pressure (e.g., lamivudine, adefovir, or entecavir) HBV mutants are selected from the pre-existing pool of quasispecies and over time become the dominant species. Not all mutations result in replication competent virus as HBV has the added complexity of overlapping reading frames. The HBV polymerase (Pol) gene overlaps the hepatitis B surface antigen (HBsAg) in a frame-shifted manner with the result that drug-resistant mutations in the HBV Pol can directly impact on the nature of HBsAg and its function. HBV genomic databases have been established to monitor antiviral selected mutations and are useful in determining conserved residues, genotypic differences, polymorphisms, and the mutation profiles selected under different antiviral selection pressures. These HBV databases may aid in the development of new diagnostic reagents as well as the monitoring of polymerase and envelope mutations selected under different antiviral pressures. Antiviral drug resistant mutants emerge as a function of at least six factors: the viral mutatio...Continue Reading

References

Nov 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·J SummersI Millman
Mar 5, 1996·Proceedings of the National Academy of Sciences of the United States of America·Y C ChenW Mandecki
Oct 26, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Y BenhamouT Poynard
Mar 29, 2003·Journal of Hepatology·Fatih BesisikAtilla Okten
Jun 28, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Christopher E WestlandUNKNOWN 437 and 438 Study Teams

❮ Previous
Next ❯

Citations

Apr 16, 2008·Journal of Gastroenterology and Hepatology·David M Iser, Joseph J Sasadeusz
Jan 12, 2010·HIV Medicine·G BrookUNKNOWN BHIVA Viral Hepatitis Working Group
Jun 13, 2012·Microbiology and Molecular Biology Reviews : MMBR·Esteban DomingoCelia Perales
Jan 16, 2007·Virology Journal·Martha-Eugenia Ruiz-TachiquínMa-Teresa Alvarez-Muñoz
Sep 25, 2008·Future Microbiology·George V Papatheodoridis, Melanie Deutsch
Dec 6, 2008·World Journal of Gastroenterology : WJG·George V PapatheodoridisAthanasios J Archimandritis
Feb 18, 2009·World Journal of Gastroenterology : WJG·Rebecca PastorEvelyne Schvoerer
Sep 6, 2013·Molekuliarnaia genetika, mikrobiologiia i virusologiia·Aylin DogenGurol Emekdas
May 26, 2009·Medicina clínica·Mario Rodríguez DominguezMarisa Mateos Lindemann
Mar 14, 2007·Virus Research·Esteban Domingo, Jordi Gomez
Sep 29, 2009·Journal of Viral Hepatitis·P GrabarczykUNKNOWN Polish Blood Transfusion Centres Viral Study Group
Sep 30, 2015·Future Medicinal Chemistry·Maxime BessièresLuigi A Agrofoglio
Apr 26, 2012·The International Journal of Biochemistry & Cell Biology·Eleftherios MichailidisStefan G Sarafianos
Mar 11, 2008·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Emmet B KeeffeYves Benhamou
Jul 23, 2013·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Zhe XuChangqing Zeng
Apr 13, 2010·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·M SayanM B Cekmen
Jul 13, 2016·Biochemical and Biophysical Research Communications·Youjia YuFeijun Huang
Apr 5, 2014·The Journal of Organic Chemistry·Uma S SinghChung K Chu
May 10, 2008·The Journal of Antimicrobial Chemotherapy·Marcelle BottecchiaVincent Soriano
Oct 18, 2011·The Journal of Antimicrobial Chemotherapy·Chih-Lang LinChau-Ting Yeh
Dec 7, 2007·The Lancet Infectious Diseases·George V PapatheodoridisAthanasios J Archimandritis
Apr 20, 2006·Journal of Medical Virology·Gerald Schochetman, Mary C Kuhns
Jan 2, 2007·Current Opinion in Infectious Diseases·Gail Matthews
Jan 13, 2016·World Journal of Gastroenterology : WJG·Patrizia CaligiuriBianca Bruzzone

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.